AUS
NZ
UK
CA
USA
IND
Stocks
Azer-cel Trial Momentum Puts Imugene in the Spotlight
December 05, 2025 06:24 PM AEDT| By SamThis article explains the latest clinical progress from Imugene’s azer-cel study, the response trends observed across two patient groups, and how the development fits into broader biotechnology activity on the ASX stock market.
RIO’s Key Valuation Signals Investors Are Watching Closely
December 05, 2025 06:16 PM AEDT| By SamA detailed look into how the valuation of Rio Tinto is shaped by core business metrics, industry forces, and the evolving dynamics across the Australian resources landscape.
AI-Driven Drug Discovery Gains Momentum With New AlgoraeOS Milestone
December 05, 2025 06:02 PM AEDT| By SamAlgorae Pharmaceuticals advances its AI drug-combination platform through independent validation and a new version launch, strengthening its roadmap for future oncology and therapeutic research programs.
Askari Metals Sets the Stage for Expanded Exploration at Nejo
December 05, 2025 05:54 PM AEDT| By SamThis article covers Askari Metals’ funding milestone, maiden drilling at Nejo, regional copper-gold exploration, and strengthened leadership guiding its broader African project strategy.
Solar Hydrogen Breakthrough Sets New Momentum for Sparc Technologies
December 05, 2025 05:09 PM AEDT| By SamSparc Technologies advances its solar-driven hydrogen project as operational testing begins at its Roseworthy pilot plant, marking a key step for future renewable energy pathways.
ZIP and Scentre Group: A Closer Look at Two ASX Retail Plays
December 05, 2025 04:39 PM AEDT| By SamThis article explores the latest developments surrounding Zip Co and Scentre Group, reviewing their business models, valuations, and broader retail sector trends across the ASX landscape.
Is Westpac’s Value Clear? Two Ways Analysts Estimate WBC
December 05, 2025 04:35 PM AEDT| By SamA detailed, user-friendly article explaining two methods analysts use to estimate the value of Westpac Banking Corp (ASX:WBC), including ratio-based and dividend-focused valuation approaches.
Are ALL or A2M Shares Offering Better Value Ahead?
December 05, 2025 04:01 PM AEDT| By SamAn in-depth comparison of ALL and A2M, exploring business strengths, sector trends, and market positioning for long-term watchers across the ASX.
CSL (ASX:CSL): Reset, Buyback Focus And What To Watch Next
December 05, 2025 12:53 PM AEDT| By SamCSL is navigating a reset phase while progressing capital management and expanding manufacturing capability. Investors are watching execution signals, facility milestones and communication clarity as the healthcare heavyweight works to rebuild moment...
ASX 200 Gold Stock Advances: What’s Next For Emerald?
December 05, 2025 12:51 PM AEDT| By SamEmerald Resources rose after reporting key approvals for the Dingo Range project in Western Australia. The update highlighted advancing development activity and strengthened the project’s pathway toward on-site execution.
Step One (ASX:STP) Hits Fresh Low as Demand Weakens
December 05, 2025 12:33 PM AEDT| By SamStep One hit a fresh low after flagging softer demand, inventory write-downs and a likely operating loss. Attention now shifts to inventory control, cash discipline and signs that margins can stabilise.
ASX 200 Check: Which Looks Better Value in 2025, ALL or A2M?
December 05, 2025 12:27 PM AEDT| By SamAristocrat and a2 Milk suit different valuation lenses. Aristocrat often aligns with earnings and cash conversion signals, while a2 Milk aligns with revenue and margin momentum. “Better value” depends on expectations versus fundamentals.
DOW and MQG Shares Step Into the Spotlight on the ASX
December 05, 2025 12:27 PM AEDT| By SamThis article explores recent activity surrounding Downer EDI and Macquarie Group, outlining their business landscapes, financial traits, and sector relevance across the ASX stock market.
Pacgold’s White Dam Deal Sets a Faster Path to Gold Production
December 05, 2025 12:21 PM AEDT| By SamPacgold has completed its White Dam acquisition, adding an established heap leach operation in South Australia. A staged restart plan begins with heap recovery, then drilling and approvals to support broader mining and growth.
Northern Star’s New Discoveries Strengthen Global Gold Growth Path
December 05, 2025 12:20 PM AEDT| By SamA detailed look at Northern Star’s latest exploration progress across Australia and Alaska, covering drilling success, growth areas, and integration of the Hemi project within the broader gold development strategy.
Mithril Expands Mexican Footprint with La Dura Option Move
December 05, 2025 12:11 PM AEDT| By SamA detailed look at Mithril Silver and Gold’s expansion in Mexico through the La Dura option, highlighting exploration plans, district growth potential, and broader activity across the ASX mining landscape.
Exploring How Westpac Shares Are Valued on the ASX
December 05, 2025 12:06 PM AEDT| By SamThis article explores how Westpac Banking Corp shares are valued through simple valuation approaches, including earnings-based and dividend-based frameworks, while examining broader ASX market context.
Askari Metals Pushes Ahead With Expanded Africa Exploration
December 05, 2025 11:59 AM AEDT| By SamAskari Metals progresses its Africa exploration plans, supported by new funding that advances drilling at Nejo and renewed rare-metal work at Uis, strengthening its position across key mineral belts.
ASX 200 Spotlight: West Tech Fest Puts WA Innovation on Stage
December 05, 2025 11:48 AM AEDT| By SamWest Tech Fest returns in December across Perth, bringing founders, investors and researchers together through major showcases and targeted sessions. The event highlights WA’s innovation depth and diversification momentum.
Entropy Doses First Patient in IV Psilocin BED Trial
December 05, 2025 11:41 AM AEDT| By SamEntropy has dosed the first patient in its TRP-8803 trial for binge eating disorder, using IV psilocin with supportive therapy. The next focus is enrolment progress and the first cohort readout.
Advertise your brand on Kalkine Media